Is a genotype-guided therapy the optimal strategy to personalize anti-thrombotic management in patients with acute coronary syndrome?

Wout W A van den Broek, Jurriën M Ten Berg
This commentary refers to 'Towards personalized antithrombotic management with drugs and devices across the cardiovascular spectrum', by T. Lüscher et al., https://
doi:10.1093/eurheartj/ehac219 pmid:35678582 fatcat:lxrmxdsmm5czvafbdf677fk2ta